What is the recommended treatment for a 19-year-old patient with a 5.5mm Ureteropelvic Junction (UPJ) stone and moderate hydronephrosis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: August 13, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment for 19-Year-Old with 5.5mm UPJ Stone and Moderate Hydronephrosis

For a 19-year-old patient with a 5.5mm ureteropelvic junction stone and moderate hydronephrosis, ureteroscopy (URS) is the recommended first-line treatment due to its superior stone-free rate compared to other interventions. 1

Initial Assessment and Considerations

Immediate Evaluation

  • Assess for signs of infection (fever, elevated WBC, pyuria)
    • If infection is suspected, urgent drainage via ureteral stent or nephrostomy tube is mandatory before discharge 2
    • Obtain urinalysis and urine culture if infection is suspected 2
  • Evaluate pain control and renal function (serum creatinine)
  • Confirm stone size and location with appropriate imaging

Treatment Decision Algorithm

  1. If no infection and pain is controlled:

    • Consider observation with medical expulsive therapy (MET) using alpha-blockers
    • Stone size (5.5mm) and location (UPJ) make spontaneous passage less likely but possible
    • Stone-free rates with observation alone average 35% for stones >5mm 1
  2. If observation/MET is chosen:

    • Limit conservative therapy to maximum of 6 weeks to avoid irreversible kidney damage 1
    • Monitor with periodic imaging to assess stone position and hydronephrosis 2
    • Follow up within 1-2 weeks to confirm stone passage or determine need for intervention 2
  3. If intervention is required (recommended in this case):

    • First-line: Ureteroscopy (URS)

      • Offers superior stone-free rate (95%) compared to SWL (87%) for ureteral stones <10mm 1
      • Lower complication rate than PCNL
      • Use of safety guidewire recommended during procedure 1
    • Alternative: Shock Wave Lithotripsy (SWL)

      • Consider if patient declines URS
      • Lower stone-free rate in a single procedure compared to URS 1
      • Lowest morbidity and complication rate among interventional options 1

Important Considerations

Pre-Procedure

  • Administer antimicrobial prophylaxis prior to intervention based on local antibiogram 1
  • Abort procedure and establish drainage if purulent urine is encountered during intervention 1

Post-Procedure

  • Stone material should be sent for analysis to guide prevention strategies 1
  • Consider metabolic evaluation to prevent recurrence

Special Considerations for Young Patients

  • URS appears to have a high success rate in pediatric/young adult patients (around 85%) 1
  • Complication rates may be somewhat higher with URS (12.4%-20.5%) compared to SWL (8%-10%) 1
  • The presence of moderate hydronephrosis suggests potential obstruction, which increases the urgency for intervention

Pitfalls to Avoid

  • Do not delay intervention beyond 6 weeks if observation is chosen, as this risks irreversible kidney injury 1
  • Do not discharge patient without intervention if infection is suspected with obstruction 2
  • Avoid routine stenting prior to URS in young patients, as access to the upper tract is usually possible on initial attempt 1
  • Do not overlook the possibility of anatomical abnormalities (such as congenital UPJ obstruction) that may complicate stone management 3

The presence of moderate hydronephrosis with a 5.5mm stone at the UPJ warrants intervention, with ureteroscopy being the most effective approach to achieve stone clearance while minimizing complications in this young patient.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Management of Obstructive Kidney Stones

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Related Questions

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.